173 related articles for article (PubMed ID: 11476942)
1. Calcitonin is a prostate epithelium-derived growth stimulatory peptide.
Chien J; Ren Y; Qing Wang Y; Bordelon W; Thompson E; Davis R; Rayford W; Shah G
Mol Cell Endocrinol; 2001 Jul; 181(1-2):69-79. PubMed ID: 11476942
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.
Sabbisetti VS; Chirugupati S; Thomas S; Vaidya KS; Reardon D; Chiriva-Internati M; Iczkowski KA; Shah GV
Int J Cancer; 2005 Nov; 117(4):551-60. PubMed ID: 15929083
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transients.
Shah GV; Rayford W; Noble MJ; Austenfeld M; Weigel J; Vamos S; Mebust WK
Endocrinology; 1994 Feb; 134(2):596-602. PubMed ID: 8299557
[TBL] [Abstract][Full Text] [Related]
4. Role of stimulatory guanine nucleotide binding protein (GSalpha) in proliferation of PC-3M prostate cancer cells.
Chien J; Shah GV
Int J Cancer; 2001 Jan; 91(1):46-54. PubMed ID: 11149419
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor.
Thomas S; Chigurupati S; Anbalagan M; Shah G
Mol Endocrinol; 2006 Aug; 20(8):1894-911. PubMed ID: 16574742
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.
Thomas S; Chiriva-Internati M; Shah GV
Clin Exp Metastasis; 2007; 24(5):363-77. PubMed ID: 17487556
[TBL] [Abstract][Full Text] [Related]
7. Paracrine calcitonin in prostate cancer is linked to CD44 variant expression and invasion.
Iczkowski KA; Omara-Opyene AL; Kulkarni TR; Pansara M; Shah GV
Anticancer Res; 2005; 25(3B):2075-83. PubMed ID: 16158948
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin induces apoptosis resistance in prostate cancer cell lines against cytotoxic drugs via the Akt/survivin pathway.
Thomas S; Shah G
Cancer Biol Ther; 2005 Nov; 4(11):1226-33. PubMed ID: 16222118
[TBL] [Abstract][Full Text] [Related]
9. Profiling of the calcitonin-calcitonin receptor axis in primary prostate cancer: clinical implications and molecular correlates.
Thakkar A; Bijnsdorp IV; Geldof AA; Shah GV
Oncol Rep; 2013 Sep; 30(3):1265-74. PubMed ID: 23820954
[TBL] [Abstract][Full Text] [Related]
10. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin induces stem cell-like phenotype in prostate cancer cells.
Aldahish A; Kale A; Aljameeli A; Shah GV
Endocr Relat Cancer; 2019 Nov; 26(11):815-828. PubMed ID: 31561211
[TBL] [Abstract][Full Text] [Related]
12. Presence of calcitonin-like immunoreactivity (iCT) in human prostate gland: evidence for iCT secretion by cultured prostate cells.
Shah GV; Noble MJ; Austenfeld M; Weigel J; Deftos LJ; Mebust WK
Prostate; 1992; 21(2):87-97. PubMed ID: 1409122
[TBL] [Abstract][Full Text] [Related]
13. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
Dalkin AC; Gilrain JT; Bradshaw D; Myers CE
Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
[TBL] [Abstract][Full Text] [Related]
14. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer.
Mutaguchi K; Yasumoto H; Mita K; Matsubara A; Shiina H; Igawa M; Dahiya R; Usui T
Cancer Res; 2003 Nov; 63(22):7717-23. PubMed ID: 14633696
[TBL] [Abstract][Full Text] [Related]
15. Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium.
Tennant MK; Thrasher JB; Twomey PA; Drivdahl RH; Birnbaum RS; Plymate SR
J Clin Endocrinol Metab; 1996 Oct; 81(10):3774-82. PubMed ID: 8855837
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin stimulates the secretion of urokinase-type plasminogen activator from prostate cancer cells: its possible implications on tumor cell invasion.
Sabbisetti V; Chigurupati S; Thomas S; Shah G
Int J Cancer; 2006 Jun; 118(11):2694-702. PubMed ID: 16381004
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways.
Shah GV; Thomas S; Muralidharan A; Liu Y; Hermonat PL; Williams J; Chaudhary J
Endocr Relat Cancer; 2008 Dec; 15(4):953-64. PubMed ID: 18784182
[TBL] [Abstract][Full Text] [Related]
18. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR
Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925
[TBL] [Abstract][Full Text] [Related]
19. The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression.
Iczkowski KA; Omara-Opyene AL; Shah GV
Anticancer Res; 2006; 26(4B):2863-72. PubMed ID: 16886606
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the neuropeptides bombesin and calcitonin on the growth of prostate cell lines, PC-3, DU 145, and LNCaP].
Larrán López J; Aparicio Patino J; López Muñoz A; Vilches Troya J
Actas Urol Esp; 2000; 24(10):779-84. PubMed ID: 11199293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
